IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prasanna, G.
Right arrow Articles by Yorio, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prasanna, G.
Right arrow Articles by Yorio, T.
(Investigative Ophthalmology and Visual Science. 2002;43:2704-2713.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

Human Optic Nerve Head Astrocytes as a Target for Endothelin-1

Ganesh Prasanna1, Raghu Krishnamoorthy1, Abbot F. Clark2, Robert J. Wordinger3 and Thomas Yorio1

1 From the Department of Pharmacology and Neuroscience and the 3 Department of Anatomy & Pathology, Division of Cell Biology and Genetics, University of North Texas Health Science Center, Fort Worth, Texas; and 2 Glaucoma Research, Alcon Laboratories Ltd., Fort Worth, Texas.

PURPOSE. To determine whether human optic nerve head astrocytes (hONAs) are target cells for the actions of endothelin (ET)-1, a potent vasoactive peptide, by causing astrocyte proliferation, as occurs in glaucomatous optic nerve heads. ET-1 levels are elevated in glaucomatous eyes, and administration of ET-1 to the retina causes glial activation and optic nerve damage in animal models in a manner similar to that observed in glaucoma.

METHODS. Well-characterized hONAs were used in this study. Cell proliferation of hONAs was assessed, after ET-1 treatment under serum-free culture conditions, with both a formazan assay and [3H]thymidine uptake. ET receptor involvement for cell proliferation was determined with BQ788 (an ETB antagonist), BQ610 (an ETA antagonist), PD142893 (an ETA/B mixed antagonist), and sarafotoxin 6C (S6C; an ETB agonist). ET-1–induced intracellular calcium ([Ca2+]i) in hONAs was measured by fura-2 imaging. RT-PCR was used to determine whether hONAs express mRNA for preproET-1, ETA, and ETB receptors.

RESULTS. ET-1 (10 and 100 nM) caused a time-dependent proliferation of hONAs, which was completely blocked by PD142893, as detected by two different cell proliferation assays. The effects of ET-1 were blocked by BQ788 and were also mimicked by S6C, indicative of the involvement of ETB receptor activation. ET-1–induced elevation in [Ca2+]i, and cell proliferation were both blocked completely by the ETA antagonist BQ610, suggesting ETA receptor involvement. The hONAs expressed mRNA for ETA and ETB receptors as well as preproET-1, suggesting that these cells may also be a source for ET-1 in the optic nerve head.

CONCLUSIONS. ET-1 induces astroglial proliferation in cultured human optic nerve head astrocytes through ETA/B receptor activation. This is similar to the proliferation of ET-1 in brain astrocytes. These findings suggest that ET-1, which is elevated in glaucoma, could cause proliferation of ONAs in the optic nerve head.




This article has been cited by other articles:


Home page
IOVSHome page
N. Izumi, T. Nagaoka, E. Sato, K. Sogawa, H. Kagokawa, A. Takahashi, A. Kawahara, and A. Yoshida
Role of Nitric Oxide in Regulation of Retinal Blood Flow in Response to Hyperoxia in Cats
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4595 - 4603.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Iribarne, L. Ogawa, V. Torbidoni, C. M. Dodds, R. A. Dodds, and A. M. Suburo
Blockade of Endothelinergic Receptors Prevents Development of Proliferative Vitreoretinopathy in Mice
Am. J. Pathol., April 1, 2008; 172(4): 1030 - 1042.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Wang, W. H. Baldridge, and B. C. Chauhan
Acute Endothelin-1 Application Induces Reversible Fast Axonal Transport Blockade in Adult Rat Optic Nerve
Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 961 - 967.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. He, G. Prasanna, and T. Yorio
Endothelin-1-Mediated Signaling in the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Astrocytes
Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3737 - 3745.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. C. Johnson, L. Jia, W. O. Cepurna, T. A. Doser, and J. C. Morrison
Global Changes in Optic Nerve Head Gene Expression after Exposure to Elevated Intraocular Pressure in a Rat Glaucoma Model
Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3161 - 3177.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. He, A. Dibas, T. Yorio, and G. Prasanna
Parallel Signaling Pathways in Endothelin-1-Induced Proliferation of U373MG Astrocytoma Cells
Experimental Biology and Medicine, March 1, 2007; 232(3): 370 - 384.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Kobayashi, H. Oku, M. Fukuhara, S. Kojima, A. Komori, M. Ichikawa, K. Katsumura, M. Kobayashi, T. Sugiyama, and T. Ikeda
Endothelin-1 Enhances Glutamate-Induced Retinal Cell Death, Possibly through ETA Receptors
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4684 - 4690.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
M Emre, S Orgul, T Haufschild, S G Shaw, and J Flammer
Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma
Br. J. Ophthalmol., January 1, 2005; 89(1): 60 - 63.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. Ichikawa, Y. Okada, Y. Asai, H. Hara, K. Ishii, and M. Araie
Effects of Topically Instilled Bunazosin, an {alpha}1-Adrenoceptor Antagonist, on Constrictions Induced by Phenylephrine and ET-1 in Rabbit Retinal Arteries
Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4041 - 4048.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. E. Brooks, M. E. Kallberg, R. L. Cannon, A. M. Komaromy, F. J. Ollivier, O. E. Malakhova, W. W. Dawson, M. B. Sherwood, E. E. Kuekuerichkina, and G. N. Lambrou
Functional and Structural Analysis of the Visual System in the Rhesus Monkey Model of Optic Nerve Head Ischemia
Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1830 - 1840.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. Ahmed, K. M. Brown, D. A. Stephan, J. C. Morrison, E. C. Johnson, and S. I. Tomarev
Microarray Analysis of Changes in mRNA Levels in the Rat Retina after Experimental Elevation of Intraocular Pressure
Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1247 - 1258.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. C. Chauhan, T. L. LeVatte, C. A. Jollimore, P. K. Yu, H. A. Reitsamer, M. E. M. Kelly, D.-Y. Yu, F. Tremblay, and M. L. Archibald
Model of Endothelin-1-Induced Chronic Optic Neuropathy in Rat
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 144 - 152.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology